Dr Delphine Denoyer

STAFF PROFILE

Position

Honorary Fellow

Faculty

Faculty of Sci Eng & Built Env

Department

School of Life & Env. Sciences

Campus

Off-Campus (Home)

Contact

d.denoyer@deakin.edu.au
+61 3 924 45432

Biography

Dr Delphine Denoyer is a research fellow in the Centre for Cellular and Molecular Biology at Deakin University. She obtained her PhD in Biomedical Engineering in France in 2004, where she investigated the mechanisms of uptake of new radiopharmaceuticals in cancer cells. After being awarded a prestigious fellowship from NHMRC/INSERM (Australia/France research cooperation program), she relocated to Australia in 2007 to pursue her interest in preclinical validation of radiopharmaceuticals for imaging and therapy of cancers at the Peter MacCallum Cancer Centre, Melbourne. In November 2013, she joined the Metals in Medicine Laboratory. Her research focus moved to the metallomics field where she uses her expertise in translational research to investigate the role of copper in the development and growth of prostate cancer.

Read more on Delphine's profile

Knowledge areas

Translational Research

Cancer Biology (in particular melanoma, prostate and breast cancers)

Metallomics

Preclinical validation of new compounds for imaging and therapy of cancer

PET/SPECT imaging, autoradiography

Publications

Filter by

2020

Bifunctional aptamer-doxorubicin conjugate crosses the blood-brain barrier and selectively delivers Its payload to EpCAM-positive tumor cells

J Macdonald, D Denoyer, J Henri, A Jamieson, I Burvenich, N Pouliot, S Shigdar

(2020), Vol. 30, pp. 117-128, Nucleic acid therapeutics, New Rochelle, N.Y., C1

journal article
2018

Copper complexes in cancer therapy

D Denoyer, S Clatworthy, M Cater

(2018), Vol. 18, pp. 469-506, Metallo-drugs: development and action of anticancer agents, Berlin, Germany, B1

book chapter

Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis

S Masaldan, S Clatworthy, C Gamell, P Meggyesy, A-T Rigopoulos, S Haupt, Y Haupt, D Denoyer, P Adlard, A Bush, M Cater

(2018), Vol. 14, pp. 100-115, Redox biology, Amsterdam, The Netherlands, C1

journal article

Copper accumulation in senescent cells: Interplay between copper transporters and impaired autophagy

S Masaldan, S Clatworthy, C Gamell, Z Smith, P Francis, D Denoyer, P Meggyesy, S La Fontaine, M Cater

(2018), Vol. 16, pp. 322-331, Redox biology, Amsterdam, The Netherlands, C1

journal article
2017

Sulfonation of tyrosine as a method to improve biodistribution of peptide-based radiotracers: novel (18)F-labeled cyclic RGD analogues

M Haskali, D Denoyer, W Noonan, C Culinane, C Rangger, N Pouliot, R Haubner, P Roselt, R Hicks, C Hutton

(2017), Vol. 14, pp. 1169-1180, Molecular pharmaceutics, Washington, D.C., C1-1

journal article

[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo

A Martin, A Fuzer, A Becceneri, J da Silva, R Tomasin, D Denoyer, S-H Kim, K McIntyre, H Pearson, B Yeo, A Nagpal, X Ling, H Selistre-de-Araujo, P Vieira, M Cominetti, N Pouliot

(2017), Vol. 8, pp. 72260-72271, Oncotarget, Albany, N.Y., C1

journal article
2016

Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution

D Denoyer, H Pearson, S Clatworthy, Z Smith, P Francis, R Llanos, I Volitakis, W Phillips, P Meggyesy, S Masaldan, M Cater

(2016), Vol. 7, pp. 37064-37080, Oncotarget, Albany, N.Y., C1

journal article

Ceruloplasmin is regulated by copper and lactational hormones in PMC42-LA mammary epithelial cell culture models

D Freestone, D Denoyer, M Jakab, M Ackland, M Cater, A Michalczyk

(2016), Vol. 8, pp. 941-950, Metallomics, Cambridge, Eng., C1

journal article
2015

Tumour but not stromal expression of ?3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.

R Carter, K Micocci, A Natoli, R Redvers, S Paquet-Fifield, A Martin, D Denoyer, X Ling, S Kim, R Tomasin, H Selistre-de-Arajo, R Anderson, N Pouliot

(2015), Vol. 235, pp. 760-772, Journal of Pathology, England, C1-1

journal article

Analysis of 177Lu-DOTA-octreotate therapy-induced DNA damage in peripheral blood lymphocytes of patients with neuroendocrine tumors

D Denoyer, P Lobachevsky, P Jackson, M Thompson, O Martin, R Hicks

(2015), Vol. 56, pp. 505-511, Journal of Nuclear Medicine, New York, N.Y., C1

journal article

Heterogeneous copper concentrations in cancerous human prostate tissues

D Denoyer, S Clatworthy, S Masaldan, P Meggyesy, M Cater

(2015), Vol. 75, pp. 1510-1517, Prostate, London, Eng., C1

journal article

Synthesis and in vivo evaluation of [123I]melanin-targeted agents

M Roberts, V Nguyen, M Ashford, P Berghofer, N Wyatt, A Krause-Heuer, T Pham, S Taylor, L Hogan, C Jiang, B Fraser, N Lengkeek, L Matesic, M Gregoire, D Denoyer, R Hicks, A Katsifis, I Greguric

(2015), Vol. 58, pp. 6214-6224, Journal of medicinal chemistry, Washington, DC., C1-1

journal article

Targeting copper in cancer therapy: 'copper that cancer'

D Denoyer, S Masaldan, S La Fontaine, M Cater

(2015), Vol. 7, pp. 1459-1476, Metallomics, London, Eng., C1

journal article
2014

Molecular imaging of metabolism in cancer metastasis

N Pouliot, D Denoyer

(2014), Vol. 38, pp. 124-128, Cancer Forum, C1

journal article

Foxp3 expression in macrophages associated with RENCA tumors in mice

C Devaud, C Yong, L John, J Westwood, C Duong, C House, D Denoyer, J Li, P Darcy, M Kershaw

(2014), Vol. 9, pp. 1-8, PLoS One, San Francisco, Calif., C1-1

journal article

Postchemotherapy and tumor-selective targeting with the La-specific DAB4 monoclonal antibody relates to apoptotic cell clearance

F Al-Ejeh, A Staudacher, D Smyth, J Darby, D Denoyer, C Tsopelas, R Hicks, M Brown

(2014), Vol. 55, pp. 772-779, JNM : The journal of nuclear medicine, New York, N.Y., C1-1

journal article

Bone-derived soluble factors and laminin-511 cooperate to promote migration, invasion and survival of bone-metastatic breast tumor cells

D Denoyer, N Kusuma, A Burrows, X Ling, L Jupp, R Anderson, N Pouliot

(2014), Vol. 32, pp. 63-73, Growth factors, London, England, C1-1

journal article

PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate

B Paterson, P Roselt, D Denoyer, C Cullinane, D Binns, W Noonan, C Jeffery, R Price, J White, R Hicks, P Donnelly

(2014), Vol. 43, pp. 1386-1396, Dalton transactions, Cambridge, Eng., C1-1

journal article
2012

Enhanced lithium-induced brain recovery following cranial irradiation is not impeded by inflammation

J Malaterre, C McPherson, D Denoyer, E Lai, J Hagekyriakou, S Lightowler, K Shudo, M Ernst, D Ashley, J Short, G Wheeler, R Ramsay

(2012), Vol. 1, pp. 469-479, Stem Cells Translational Medicine, C1-1

journal article

Tumour targeting of Auger emitters using DNA ligands conjugated to octreotate

P Lobachevsky, J Smith, D Denoyer, C Skene, J White, B Flynn, D Kerr, R Hicks, R Martin

(2012), Vol. 88, pp. 1009-1018, International Journal of Radiation Biology, C1-1

journal article

Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer

D Denoyer, L Kirby, K Waldeck, P Roselt, O Neels, T Bourdier, R Shepherd, A Katsifis, R Hicks

(2012), Vol. 39, pp. 703-712, European Journal of Nuclear Medicine and Molecular Imaging, C1-1

journal article

Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis

N Kusuma, D Denoyer, J Eble, R Redvers, B Parker, R Pelzer, R Anderson, N Pouliot

(2012), Vol. 130, pp. 555-566, International Journal of Cancer, C1-1

journal article
2011

Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging

M Ma, O Neels, D Denoyer, P Roselt, J Karas, D Scanlon, J White, R Hicks, P Donnelly

(2011), Vol. 22, pp. 2093-2103, Bioconjugate Chemistry, C1-1

journal article

Radiosynthesis and biological evaluation of L- and D-S-(3-[ 18F]fluoropropyl)homocysteine for tumor imaging using positron emission tomography

T Bourdier, R Shepherd, P Berghofer, T Jackson, C Fookes, D Denoyer, D Dorow, I Greguric, M Gregoire, R Hicks, A Katsifis

(2011), Vol. 54, pp. 1860-1870, Journal of Medicinal Chemistry, C1-1

journal article

Improved detection of regional melanoma metastasis using 18F-6-fluoro-N-[2-(diethylamino)ethyl] pyridine-3-carboxamide, a melanin-specific PET probe, by perilesional administration

D Denoyer, T Potdevin, P Roselt, O Neels, L Kirby, I Greguric, A Katsifis, D Dorow, R Hicks

(2011), Vol. 52, pp. 115-122, Journal of Nuclear Medicine, C1-1

journal article
2010

High-contrast PET of melanoma using 18F-MEL050, a selective probe for melanin with predominantly renal clearance

D Denoyer, I Greguric, P Roselt, O Neels, N Aide, S Taylor, A Katsifis, D Dorow, R Hicks

(2010), Vol. 51, pp. 441-447, Journal of Nuclear Medicine, C1-1

journal article

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

J Stagg, U Divisekera, N McLaughlin, J Sharkey, S Pommey, D Denoyer, K Dwyer, M Smyth

(2010), Vol. 107, pp. 1547-1552, Proceedings of the National Academy of Sciences of the United States of America, C1-1

journal article
2009

Discovery of [18F]N-(2-(diethylamino)ethyl)-6- fluoronicotinamide: A melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance

I Greguric, S Taylor, D Denoyer, P Ballantyne, P Berghofer, P Roselt, T Pham, F Mattner, T Bourdier, O Neels, D Dorow, C Loc'h, R Hicks, A Katsifis

(2009), Vol. 52, pp. 5299-5302, Journal of Medicinal Chemistry, C1-1

journal article
2008

Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent

D Denoyer, P Labarre, J Papon, E Miot-Noirault, M Galmier, J Madelmont, J Chezal, N Moins

(2008), Vol. 875, pp. 411-418, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, C1-1

journal article
2005

Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells

N Le Jeune, N Perek, D Denoyer, F Dubois

(2005), Vol. 20, pp. 249-259, Cancer biotherapy & radiopharmaceuticals, New Rochelle, N.Y., C1-1

journal article

Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines

D Denoyer, N Perek, N Le Jeune, J Cornillon, F Dubois

(2005), Vol. 32, pp. 820-827, European journal of nuclear medicine and molecular imaging, Heidelberg, Germany, C1-1

journal article
2004

Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells

N Le Jeune, N Perek, D Denoyer, F Dubois

(2004), Vol. 19, pp. 411-421, Cancer biotherapy & radiopharmaceuticals, New Rochelle, N.Y., C1-1

journal article

Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines

D Denoyer, N Perek, N Le Jeune, D Frere, F Dubois

(2004), Vol. 31, pp. 77-84, European journal of nuclear medicine and molecular imaging, Berlin, Germany, C1-1

journal article
2003

The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptake

D Denoyer, N Perek, N Le Jeune, D Frre, F Dubois

(2003), Vol. 18, pp. 791-801, Cancer biotherapy & radiopharmaceuticals, New Rochelle, N.Y., C1-1

journal article
2002

Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with TC-99M-sestamibi and TC-99M-tetrofosmin

N Perek, F Koumanov, D Denoyer, D Boudard, F Dubois

(2002), Vol. 17, pp. 291-302, Cancer biotherapy & radiopharmaceuticals, New Rochelle, N.Y., C1-1

journal article

The multidrug resistance mechanisms and their interactions with the radiopharmaceutical probes used for an In Vivo detection

N Perek, D Denoyer

(2002), Vol. 3, pp. 97-113, Current drug metabolism, Beijing, China, C1-1

journal article
undefined

Promising Pre-clinical Validation of Targeted Radionuclide Therapy Using a [131I] Labelled Iodoquinoxaline Derivative for an Effective Melanoma Treatment

Bonnet Duquennoy M

(), Vol. 01, Journal of Cancer Science & Therapy, C1-1

journal article

Funded Projects at Deakin

Industry and Other Funding

Can targeting lipid metabolism inhibit prostate cancer progression?

Dr Delphine Denoyer

  • 2017: $29,000
  • 2016: $29,000

Supervisions

No completed student supervisions to report